BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 10.06
+0.07 (0.70%)
Sep 25, 2026, 10:20 AM CET
BioMaxima Market Cap
BioMaxima has a market cap or net worth of 41.89 million as of September 24, 2026. Its market cap has decreased by -26.54% in one year.
Market Cap
41.89M
Enterprise Value
57.59M
Revenue
59.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.06
ChartMarket Cap Chart
Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 41.89M, an increase of 267.33%. That is a compound annual growth rate of 8.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 41.89M | -17.10% |
| Dec 30, 2025 | 50.53M | 12.62% |
| Dec 30, 2024 | 44.87M | -34.84% |
| Dec 29, 2023 | 68.85M | -35.28% |
| Dec 30, 2022 | 106.38M | -6.37% |
| Dec 30, 2021 | 113.62M | -4.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.49B |
| NEUCA | 3.17B |
| Synektik Spólka Akcyjna | 3.01B |
| Voxel | 1.53B |
| Read-Gene | 58.95M |
| Genomtec | 53.48M |
| Milton Essex Spólka Akcyjna | 37.56M |
| Pharmena | 34.53M |